Edwards Lifesciences (EW) Tops Q3 EPS by 9c, Q4 & FY Guidance Tops Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Canaccord Genuity Reiterates Buy on Edwards Lifesciences (EW) following 3Q Results
October 27, 2015 10:50 AM EDTCanaccord Genuity reiterated a Buy rating on Edwards Lifesciences (NYSE: EW), and raised the price target to $180.00 (from $178.00), following the company's 3Q earnings results. EW reported EPS of $1.07, beating consensus by 9c. Management does an excellent job hedging FX swings to neutralize EPS... More
UBS Raises Price Target on Edwards Lifesciences (EW) Following Strong 3Q Results
October 27, 2015 8:57 AM EDTUBS reiterated a Buy rating on Edwards Lifesciences (NYSE: EW), and raised the price target to $203.00 (from $201.00), following the company's 3Q15 earnings results. Management upped fullyear EPS guidance by $4.43-4.53 from $4.30-4.40, which assumes a touch more upside in Q4.
Analyst Matt Miksic... More
